A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity

Article metrics

Abstract

A number of agents that mimic the ability of the thryoid hormone, T3, to decrease plasma cholesterol levels are described; one is as effective as T3 at reducing cholesterol levels and stimulating liver function, but has very little effect on cardiac function and is thus less likely to be toxic. The agent may be useful in the treatment of atherosclerosis.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Aviram, M., Luboshitzky, R. & Brook, J. G. Clin. Biochem. 15, 62–66 (1982).

  2. 2

    Hansson, P., Valdemarsson, S. & Nilsson-Ehle, P. Horm. Metab. Res. 15, 449–452 (1983).

  3. 3

    Boyd, G. S. & Oliver, M. F. J. Endocrinol. 21, 25–32 (1960).

  4. 4

    Engleken, S. F. & Eaton, P. R. Atherosclerosis 38, 177–188 (1981).

  5. 5

    Cuthbertson, W. F. J., Elcoate, P. V., Ireland, D. H., Mills, D. C. B. & Shearley, P. J. Endocrin. 21, 45–63 (1960).

  6. 6

    Boyd, G. S. & Oliver, M. F. J. Endocrin. 20, 33–43 (1960).

  7. 7

    The Coronary Drug Project Research Group J. Am. med. Ass. 220, 996–1008 (1972).

  8. 8

    Scarabottolo, L., Trezzi, E., Roma, P. & Catapano, A. L. Atherosclerosis, 59, 329–333 (1986).

  9. 9

    Ridgway, N. D. & Dolphin, P. J. J. Lipid Res. 26, 1300–1313 (1985).

  10. 10

    Hulsman, W. C., Oerlemans, M. C. & Geelhoed-Mieras, M. M. Biochem. biophys. Res. Comm. 79, 784–788 (1977).

  11. 11

    Severson, D. L. & Fletcher, T. Biochim. biophys. Acta 675, 256–264 (1981).

  12. 12

    Hoffman, W. W., Richert, D. A. & Westerfeld, W. W. Endocrinology 78, 1189–1197 (1966).

  13. 13

    Oppenheimer, J. H., Schwartz, H. L., Surks, M. I., Koerner, D. & Dillman, W. H. Recent Prog. in Hormone Res. 32, 529–565 (1976).

  14. 14

    Oppenhiemer, J. H., Koerner, D., Schwartz, H. L. & Surks, M. I. J. clin. Endocr. Metab. 35, 330–333 (1972).

  15. 15

    Weisgraber, K. H. & Mahley, R. W. in Lipoprotein Studies of Non-human Species (eds Lewis, L. A. & Oppet, J. J.) 13–103 CRC Handbook of Electrophoresis, vol. IV (CRC Press, Baton Rouge, 1983).

  16. 16

    Jorgensen, E. C. in Hormonal Proteins and Peptides, Vol. VI Thyroid Hormones, (ed. Li, C. H.) 108–204 (Academic, New York, 1978).

  17. 17

    Oppenheimer, J. H. & Schwartz, H. L. J. clin. Invest. 75, 147–154 (1985).

  18. 18

    Richards, T., Horlock, H. & Gallagher, P. Animal Technology 37, 1–6 (1986).

  19. 19

    Benson, M. G. et al. Biochem. Pharmacol. 33, 3143–3149 (1984).

  20. 20

    Samuels, H. H. & Tsai, J. S. Proc. natn. Acad. Sci. U.S.A. 70, 3488–3492 (1973).

  21. 21

    Koerner, D., Schwartz, H. L., Surks, M. I. & Oppenheimer, J. H. J. biol. Chem. 250, 6417–6423 (1975).

  22. 22

    Oppenheimer, J. H., Schwartz, H. L., Dillman, W. L. & Surks, M. I. Biochem. biophys. Res. Commun. 55, 544–550 (1973).

  23. 23

    Burton, K. Biochem. J. 62, 315–323 (1956).

  24. 24

    McMahon, T. Science 179, 1201–1205 (1973).

  25. 25

    Kappagoda, C. T. & Linden, R. J. Cardiovasc. Res. 6, 589–598 (1972).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.